We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$490M
AUM Growth
-$143M
Cap. Flow
-$164M
Cap. Flow %
-33.56%
Top 10 Hldgs %
10.5%
Holding
855
New
346
Increased
61
Reduced
95
Closed
352

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.22M
2
META icon
Meta Platforms (Facebook)
META
+$6.1M
3
BSX icon
Boston Scientific
BSX
+$5.72M
4
ACN icon
Accenture
ACN
+$5.66M
5
EXPE icon
Expedia Group
EXPE
+$4.52M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$14.8M
2
ORCL icon
Oracle
ORCL
+$10.3M
3
DIS icon
Walt Disney
DIS
+$9.89M
4
AAPL icon
Apple
AAPL
+$9.74M
5
WFC icon
Wells Fargo
WFC
+$8.86M

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Consumer Discretionary 16.12%
3 Healthcare 15.86%
4 Industrials 12.65%
5 Financials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYC icon
226
Paycom
PAYC
$7.56B
$675K 0.14%
3,244
-798
-20% -$180K
APPN icon
227
Appian
APPN
$2B
$663K 0.14%
+21,692
New +$652K
CVLT icon
228
Commault Systems
CVLT
$5.1B
$661K 0.14%
3,500
+900
+35% +$162K
MTG icon
229
MGIC Investment
MTG
$6.42B
$657K 0.13%
+23,165
New +$631K
SEE
230
DELISTED
Sealed Air
SEE
$654K 0.13%
18,499
-8,500
-31% -$271K
ZETA icon
231
Zeta Global
ZETA
$5.46B
$652K 0.13%
+32,800
New +$589K
SHOP icon
232
Shopify
SHOP
$172B
$639K 0.13%
4,300
-24,200
-85% -$3.28M
BIO icon
233
Bio-Rad Laboratories Class A
BIO
$8.79B
$638K 0.13%
+2,275
New +$619K
PANW icon
234
Palo Alto Networks
PANW
$260B
$634K 0.13%
+3,114
New +$596K
VKTX icon
235
Viking Therapeutics
VKTX
$3.91B
$633K 0.13%
24,100
+7,900
+49% +$236K
DXCM icon
236
DexCom
DXCM
$29.2B
$633K 0.13%
+9,400
New +$744K
NCNO icon
237
nCino
NCNO
$2.05B
$632K 0.13%
23,309
+14,210
+156% +$415K
AMH icon
238
American Homes 4 Rent
AMH
$12.2B
$628K 0.13%
+18,900
New +$659K
ANET icon
239
Arista Networks
ANET
$211B
$627K 0.13%
+4,300
New +$554K
ARLO icon
240
Arlo Technologies
ARLO
$1.57B
$622K 0.13%
+36,700
New +$624K
FND icon
241
Floor & Decor
FND
$6.2B
$619K 0.13%
8,400
+3,000
+56% +$246K
PGNY icon
242
Progyny
PGNY
$2.38B
$618K 0.13%
+28,700
New +$652K
UDR icon
243
UDR
UDR
$12.7B
$615K 0.13%
+16,500
New +$644K
SF
244
Stifel
SF
$12.7B
$613K 0.13%
+8,100
New +$606K
MAT icon
245
Mattel
MAT
$4.46B
$608K 0.12%
+36,124
New +$658K
PR
246
Permian Resources
PR
$16.5B
$607K 0.12%
47,400
-800
-2% -$11K
MATX icon
247
Matsons
MATX
$6.16B
$606K 0.12%
+6,150
New +$657K
RRR icon
248
Red Rock Resorts
RRR
$3.85B
$598K 0.12%
+9,800
New +$577K
HQY icon
249
HealthEquity
HQY
$8.44B
$597K 0.12%
6,300
-13,200
-68% -$1.24M
BLBD icon
250
Blue Bird Corp
BLBD
$2.31B
$593K 0.12%
+10,300
New +$537K

Similar funds

Bayesian Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Bayesian Capital Management held 855 positions worth $490M, down 23% from $633M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Bayesian Capital Management withdrew a net $164M in Q3 2025, closing 352 positions and reducing 95 holdings. Its most notable exit was Nike, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Microsoft worth $6.32M.

  • Bayesian Capital Management's largest Q3 2025 buy was Microsoft: 12,200 shares worth $6.32M.
  • Bayesian Capital Management added most to Idexx Laboratories in Q3 2025, an estimated $3.81M increase.
  • Bayesian Capital Management's biggest Q3 2025 reduction was Walt Disney, cutting an estimated $9.89M.
  • Bayesian Capital Management fully exited Nike in Q3 2025, selling an estimated $14.8M.
  • Bayesian Capital Management's ten largest holdings make up 10% of its $490M portfolio in Q3 2025.
  • Bayesian Capital Management opened 346 new positions and closed 352 in Q3 2025.
  • Bayesian Capital Management's portfolio value fell 23% quarter-over-quarter to $490M.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.